Literature DB >> 17600847

Perturbation of mouse glioma MRS pattern by induced acute hyperglycemia.

R V Simões1, M L García-Martín, S Cerdán, C Arús.   

Abstract

(1)H MRS is evolving into an invaluable tool for brain tumor classification in humans based on pattern recognition analysis, but there is still room for improvement. Here we propose a new approach: to challenge tumor metabolism in vivo by a defined perturbation, and study the induced changes in MRS pattern. For this we recorded single voxel (1)H MR spectra from mice bearing a stereotactically induced GL261 grade IV brain glioma during a period of induced acute hyperglycemia. A total of 29 C57BL/6 mice were used. Single voxel spectra were acquired at 7 T with point resolved spectroscopy and TE of 12, 30 and 136 ms. Tumors were induced by stereotactic injection of 10(5) GL261cells in 17 mice. Hyperglycemia (up to 338 +/- 36 mg/dL glucose in the blood) was induced by intraperitoneal bolus injection. Maximal increases in glucose resonances of up to 2.4-fold were recorded from tumors in vivo. Our observations are in agreement with extracellular accumulation of glucose, which may suggest that glucose transport and/or metabolism are working close to their maximum capacity in GL261 tumors. The significant and specific MRS pattern changes observed when comparing euglycemia and hyperglycemia may be of use for future pattern-recognition studies of animal and human brain tumors by enhancing MRS-based discrimination between tumor types and grades. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17600847     DOI: 10.1002/nbm.1188

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  14 in total

1.  Minimization of spectral pattern changes during HRMAS experiments at 37 degrees celsius by prior focused microwave irradiation.

Authors:  Myriam Davila; Ana Paula Candiota; Martí Pumarola; Carles Arus
Journal:  MAGMA       Date:  2012-10       Impact factor: 2.310

2.  Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation.

Authors:  Magdalena Ciezka; Milena Acosta; Cristina Herranz; Josep M Canals; Martí Pumarola; Ana Paula Candiota; Carles Arús
Journal:  J Neurooncol       Date:  2016-06-21       Impact factor: 4.130

3.  Protein Kinase CK2 Content in GL261 Mouse Glioblastoma.

Authors:  Laura Ferrer-Font; Estefania Alcaraz; Maria Plana; Ana Paula Candiota; Emilio Itarte; Carles Arús
Journal:  Pathol Oncol Res       Date:  2015-10-14       Impact factor: 3.201

4.  Metal-Free Radical Dendrimers as MRI Contrast Agents for Glioblastoma Diagnosis: Ex Vivo and In Vivo Approaches.

Authors:  Songbai Zhang; Vega Lloveras; Silvia Lope-Piedrafita; Pilar Calero-Pérez; Shuang Wu; Ana Paula Candiota; José Vidal-Gancedo
Journal:  Biomacromolecules       Date:  2022-06-24       Impact factor: 6.978

5.  Multiparametric MR imaging of tumor response to intraarterial chemotherapy in orthotopic xenograft models of human metastatic brain tumor.

Authors:  Byungjun Kim; Keonha Kim; Keun Ho Im; Jae-Hoon Kim; Jung Hee Lee; Pyoung Jeon; Hongsik Byun
Journal:  J Neurooncol       Date:  2016-01-08       Impact factor: 4.130

6.  Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma.

Authors:  Rachel L Derr; Xiaobu Ye; Melissa U Islas; Serena Desideri; Christopher D Saudek; Stuart A Grossman
Journal:  J Clin Oncol       Date:  2009-01-12       Impact factor: 44.544

7.  Plasma levels of glucose and insulin in patients with brain tumors.

Authors:  Oana Alexandru; L Ene; Oana Stefana Purcaru; Daniela Elise Tache; Alisa Popescu; Oana Maria Neamtu; Ligia Gabriela Tataranu; Ada Maria Georgescu; Valerica Tudorica; Cornelia Zaharia; Anica Dricu
Journal:  Curr Health Sci J       Date:  2013-12-29

8.  A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study.

Authors:  Ana Paula Candiota; Milena Acosta; Rui Vasco Simões; Teresa Delgado-Goñi; Silvia Lope-Piedrafita; Ainhoa Irure; Marco Marradi; Oscar Bomati-Miguel; Nuria Miguel-Sancho; Ibane Abasolo; Simó Schwartz; Jesús Santamaria; Soledad Penadés; Carles Arús
Journal:  J Nanobiotechnology       Date:  2014-04-05       Impact factor: 10.435

9.  Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses.

Authors:  Pilar Calero-Pérez; Shuang Wu; Carles Arús; Ana Paula Candiota
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

10.  Convex non-negative matrix factorization for brain tumor delimitation from MRSI data.

Authors:  Sandra Ortega-Martorell; Paulo J G Lisboa; Alfredo Vellido; Rui V Simões; Martí Pumarola; Margarida Julià-Sapé; Carles Arús
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.